Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

BackgroundNeoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the optimal treatment strategy and sequence remain inconclusive....

Full description

Bibliographic Details
Main Authors:	Tzu-Chieh Yin, Po-Jung Chen, Yung-Sung Yeh, Ching-Chun Li, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang, Chun-Ming Huang, Hsiang-Lin Tsai, Jaw-Yuan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	metastatic rectal cancer locally advanced rectal cancer concurrent radiotherapy primary tumor resection (PTR) systemic chemotherapy systemic targeted therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1099168/full

Similar Items

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer
by: Tzu-Chieh Yin, et al.
Published: (2020-10-01)

Low Ligation Plus High Dissection Versus High Ligation of the Inferior Mesenteric Artery in Sigmoid Colon and Rectal Cancer Surgery: A Meta-Analysis
by: Tzu-Chieh Yin, et al.
Published: (2021-11-01)

Feasibility of robot-assisted surgery in elderly patients with rectal cancer
by: Wei-Chih Su, et al.
Published: (2021-01-01)

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
by: Chun-Ming Huang, et al.
Published: (2022-07-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
by: Chun-Ming Huang, et al.
Published: (2021-09-01)

Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
by: Po-Jung Chen, et al.
Published: (2021-07-01)

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting <i>c-Met</i>
by: Chun-Ming Huang, et al.
Published: (2021-10-01)

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
by: Ming-Yii Huang, et al.
Published: (2018-03-01)

Smartband Use During Enhanced Recovery After Surgery Facilitates Inpatient Recuperation Following Minimally Invasive Colorectal Surgery
by: Tzu-Chieh Yin, et al.
Published: (2021-01-01)

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study
by: Hon-Yi Shi, et al.
Published: (2022-03-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis
by: Yi-Ting Chen, et al.
Published: (2020-02-01)

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer
by: Yen-Cheng Chen, et al.
Published: (2021-01-01)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
by: Jen-Hao Yeh, et al.
Published: (2022-06-01)

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous polymorphism: a single-center case series
by: Hsiang-Lin Tsai, et al.
Published: (2022-07-01)

Comparing efficacy and safety between Naldebain ® and intravenous patient-controlled analgesia with fentanyl for pain management post-laparotomy: study protocol for a randomized controlled, non-inferior trial
by: Hsiang-Lin Tsai, et al.
Published: (2019-03-01)

Robot-assisted restorative proctectomy with coloanal anastomosis for anorectal malignant melanoma: An unusual case report
by: Yi-Chien Hsieh, et al.
Published: (2020-01-01)

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer
by: Ching-Wen Huang, et al.
Published: (2021-07-01)

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy.
by: Ching-Wen Huang, et al.
Published: (2020-01-01)

Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial
by: Cheng-Jen Ma, et al.
Published: (2019-12-01)

Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer
by: Jen-Pin Chuang, et al.
Published: (2022-11-01)

Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting
by: Cheng-Jen Ma, et al.
Published: (2019-03-01)

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis
by: Yen-Cheng Chen, et al.
Published: (2023-12-01)

Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer
by: Wei-Chih Su, et al.
Published: (2022-04-01)

Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial
by: Tsung-Kun Chang, et al.
Published: (2020-09-01)

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer
by: Wei-Chih Su, et al.
Published: (2018-01-01)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
by: Hsiang-Lin Tsai, et al.
Published: (2022-05-01)

An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
by: Chun-Ming Huang, et al.
Published: (2016-09-01)

Ectopic pancreas mimicking gastric submucosal tumour treated using robotic surgery
by: Tsung-Kun Chang, et al.
Published: (2020-01-01)

A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
by: Yu-Tang Chang, et al.
Published: (2016-01-01)

Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in <i>BRAF<sup>V600E</sup></i>-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study
by: Hsiang-Lin Tsai, et al.
Published: (2023-12-01)

Clinical Safety and Effectiveness of Robotic-Assisted Surgery in Patients with Rectal Cancer: Real-World Experience over 8 Years of Multiple Institutions with High-Volume Robotic-Assisted Surgery
by: Ching-Wen Huang, et al.
Published: (2022-08-01)

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy
by: I-Ping Yang, et al.
Published: (2019-08-01)

Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
by: Yung-Sung Yeh, et al.
Published: (2017-04-01)

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in <i>BRAF</i>-Mutated Metastatic Colorectal Cancer—A Case Series Study <i>Target Therapy of</i> BRAF-<i>Mutated mCRC</i>
by: Jen-Hao Yeh, et al.
Published: (2021-12-01)

Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice
by: Kwan-Ling Yip, et al.
Published: (2022-04-01)

Gut Fecal Microbiota Transplant in a Mouse Model of Orthotopic Rectal Cancer
by: Yen-Cheng Chen, et al.
Published: (2020-10-01)

MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review
by: I-Ping Yang, et al.
Published: (2023-02-01)

Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes
by: Hsiu-Chung Cheng, et al.
Published: (2021-07-01)

Advanced gastric cancer presenting as a submucosal tumor of the stomach
by: Yen‐Cheng Chen, et al.
Published: (2019-06-01)